Application for quotation of securities - BLS

Sep 4, 2026 at 3:07 AM EDT · Issued by BLS Pharmaceuticals Limited via ASX

Filed with ASX · Sep 4, 2026 at 3:07 AM EDT

On 6ix: 6ix.com/news/application-for-quotation-of-securities-bls-4

Appendix 2A - Application for quotation of securities Appendix 2A - Application for quotation of securities 1 / 8 Announcement Summary Entity name BLS PHARMACEUTICALS LIMITED Announcement Type New announcement Date of this announcement Friday September 04, 2026 The +securities to be...

View Attachment

6ix hasn’t read this filing yet.

BLS Pharmaceuticals Limited on 6ix

Earlier from BLS Pharmaceuticals

Appendix 4G Corporate Governance StatementAug 31
BLS FY2027 GuidanceAug 30
BLS Investor PresentationAug 30
BLS FY2026 Results AnnouncementAug 30
Annual Report to shareholdersAug 30

Later from BLS Pharmaceuticals

S&P DJI Announces September 2026 Quarterly RebalanceSep 4
Angus Walker Appointed Alternate Director to Edward MyerSep 13
Initial Director's Interest NoticeSep 14
AGM Date and Director NominationsOct 6
Becoming a substantial holderOct 8

All BLS Pharmaceuticals news releases

Follow BLS Pharmaceuticals into a list and get an email when it puts out news.

Follow BLS Pharmaceuticals